Ascletis Pharma Inc. (HKG:1672)

Hong Kong · Delayed Price · Currency is HKD

16.87

-0.79 (-4.47%)

Feb 23, 2026, 4:08 PM HKT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals	1.28M	56.60M	54.09M	76.88M	35.00M
Pharmaceuticals Growth	-97.73%	4.63%	-29.64%	119.64%	-79.82%
Total	1.28M	56.60M	54.09M	76.88M	35.00M
Total Growth	-97.73%	4.63%	-29.64%	119.64%	-79.82%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Other region	1.28M	-	26.00K	5.93M	-
Other region Growth	-	-	-99.56%	-	-
Mainland China	-	56.60M	54.06M	70.95M	35.00M
Mainland China Growth	-	4.68%	-23.80%	102.71%	-79.66%
Total	1.28M	56.60M	54.09M	76.88M	35.00M
Total Growth	-97.73%	4.63%	-29.64%	119.64%	-79.82%

Source: S&P Global Market Intelligence.